Latest News

Features

The ‘paclitaxel evidence lifecycle’ and the case for faster, more innovative...

Weighing in on the fallout from the recent European Society for Vascular Surgery (ESVS) focused update on paclitaxel devices, Matt Popplewell (Leicester, UK), Thanos...

Multinational trial of low-cost drug targets primary inflammation in PAD patients

As the global burden of peripheral arterial disease (PAD) continues to rise, so too does the need for strategies to reduce an “unacceptably high”...

Videos

In part two of a Charing Cross (CX) Symposium special roundtable discussion on the use of drug-based technology use in the lower extremity, Peter...

Most read

Features

Profiles

Anahita Dua

Kak Khee Yeung

Marianne Brodmann